Elisabeth Turpin

1.0k total citations
17 papers, 810 citations indexed

About

Elisabeth Turpin is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Elisabeth Turpin has authored 17 papers receiving a total of 810 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Elisabeth Turpin's work include Cancer-related Molecular Pathways (7 papers), Cancer Genomics and Diagnostics (5 papers) and Toxin Mechanisms and Immunotoxins (4 papers). Elisabeth Turpin is often cited by papers focused on Cancer-related Molecular Pathways (7 papers), Cancer Genomics and Diagnostics (5 papers) and Toxin Mechanisms and Immunotoxins (4 papers). Elisabeth Turpin collaborates with scholars based in France, United States and Belgium. Elisabeth Turpin's co-authors include Hugues de Thé, Anne Janin, Louis‐François Plassa, Philippe Bertheau, Marc Espié, Mariana Varna, Jacqueline Lehmann‐Che, Anne de Roquancourt, Sylvie Giacchetti and Annette Alfsen and has published in prestigious journals such as Blood, Diabetes Care and Cancer Research.

In The Last Decade

Elisabeth Turpin

17 papers receiving 790 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elisabeth Turpin France 13 431 410 320 109 89 17 810
Sujatha Jagadeeswaran United States 12 360 0.8× 465 1.1× 197 0.6× 169 1.6× 76 0.9× 16 973
Qiong Xue China 13 258 0.6× 451 1.1× 309 1.0× 59 0.5× 68 0.8× 22 872
Louis‐François Plassa France 12 549 1.3× 398 1.0× 377 1.2× 111 1.0× 81 0.9× 14 834
Delphine S. Ally United States 4 683 1.6× 634 1.5× 301 0.9× 85 0.8× 82 0.9× 4 1.1k
Peter Čamaj Germany 16 355 0.8× 507 1.2× 279 0.9× 78 0.7× 52 0.6× 22 788
Ariel Ka-Man Chow Hong Kong 16 624 1.4× 672 1.6× 440 1.4× 110 1.0× 96 1.1× 27 1.2k
Mitsuchika Hosoda Japan 17 544 1.3× 477 1.2× 281 0.9× 100 0.9× 100 1.1× 37 895
Chikashi Kihara Japan 10 338 0.8× 704 1.7× 167 0.5× 96 0.9× 112 1.3× 18 984
Susann Weissmueller United States 5 414 1.0× 725 1.8× 250 0.8× 119 1.1× 70 0.8× 6 992
Sarab Lizard‐Nacol France 18 393 0.9× 627 1.5× 331 1.0× 261 2.4× 160 1.8× 33 1.1k

Countries citing papers authored by Elisabeth Turpin

Since Specialization
Citations

This map shows the geographic impact of Elisabeth Turpin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisabeth Turpin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisabeth Turpin more than expected).

Fields of papers citing papers by Elisabeth Turpin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisabeth Turpin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisabeth Turpin. The network helps show where Elisabeth Turpin may publish in the future.

Co-authorship network of co-authors of Elisabeth Turpin

This figure shows the co-authorship network connecting the top 25 collaborators of Elisabeth Turpin. A scholar is included among the top collaborators of Elisabeth Turpin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisabeth Turpin. Elisabeth Turpin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Bertheau, Philippe, Jacqueline Lehmann‐Che, Mariana Varna, et al.. (2013). p53 in breast cancer subtypes and new insights into response to chemotherapy. The Breast. 22. S27–S29. 151 indexed citations
2.
Dubosq, Francis, Guillaume Ploussard, Hany Soliman, et al.. (2011). Identification of a three-gene expression signature of early recurrence in non-muscle-invasive urothelial cell carcinoma of the bladder. Urologic Oncology Seminars and Original Investigations. 30(6). 833–840. 14 indexed citations
3.
Lehmann‐Che, Jacqueline, Fabrice André, Christine Desmedt, et al.. (2010). Cyclophosphamide Dose Intensification May Circumvent Anthracycline Resistance of p53 Mutant Breast Cancers. The Oncologist. 15(3). 246–252. 41 indexed citations
4.
Manié, Élodie, Anne Vincent‐Salomon, Jacqueline Lehmann‐Che, et al.. (2009). High Frequency of TP53 Mutation in BRCA1 and Sporadic Basal-like Carcinomas but not in BRCA1 Luminal Breast Tumors. Cancer Research. 69(2). 663–671. 112 indexed citations
5.
Bertheau, Philippe, Marc Espié, Elisabeth Turpin, et al.. (2008). <i>TP53</i> Status and Response to Chemotherapy in Breast Cancer. Pathobiology. 75(2). 132–139. 90 indexed citations
6.
Varna, Mariana, Jacqueline Lehmann‐Che, Elisabeth Turpin, et al.. (2008). p53 dependent cell‐cycle arrest triggered by chemotherapy in xenografted breast tumors. International Journal of Cancer. 124(4). 991–997. 39 indexed citations
7.
Bertheau, Philippe, Elisabeth Turpin, David S. Rickman, et al.. (2007). Exquisite Sensitivity of TP53 Mutant and Basal Breast Cancers to a Dose-Dense Epirubicin−Cyclophosphamide Regimen. PLoS Medicine. 4(3). e90–e90. 132 indexed citations
8.
Lehmann‐Che, Jacqueline, Elisabeth Turpin, Philippe Bertheau, Marc Espié, & Hugues de Thé. (2007). La fonction de TP53. médecine/sciences. 23(11). 1021–1023. 3 indexed citations
9.
Zhao, Weili, Marjan Daneshpouy, Nicolas Mounier, et al.. (2003). Prognostic significance of bcl-xL gene expression and apoptotic cell counts in follicular lymphoma. Blood. 103(2). 695–697. 53 indexed citations
10.
Bertheau, Philippe, Florence Lerebours, Anne de Roquancourt, et al.. (2001). Allelic Loss Detection in Inflammatory Breast Cancer: Improvement with Laser Microdissection. Laboratory Investigation. 81(10). 1397–1402. 30 indexed citations
11.
Turpin, Elisabeth, B Dalle, Anne de Roquancourt, et al.. (1999). Stress-induced aberrant splicing of TSG101: association to high tumor grade and p53 status in breast cancers. Oncogene. 18(54). 7834–7837. 26 indexed citations
13.
Velho, Gilberto, Elisabeth Turpin, Dominique Néel, et al.. (1993). Lipoprotein(a) in Diabetic Patients and Normoglycemic Relatives in Familial NIDDM. Diabetes Care. 16(5). 742–747. 37 indexed citations
14.
Emmanuel, Florence, Elisabeth Turpin, Annette Alfsen, & Jean‐Pierre Frénoy. (1988). Separation of ricin A- and B-chains after dithiothreitol reduction. Analytical Biochemistry. 173(1). 134–141. 16 indexed citations
15.
Turpin, Elisabeth, et al.. (1984). Nature of the interaction between Ricinus communis agglutinin and blood cells. FEBS Letters. 175(1). 82–86. 2 indexed citations
16.
Turpin, Elisabeth, et al.. (1984). Nature of the receptor sites for galactosyl-specific lectins on human lymphocytes. Experimental Cell Research. 152(2). 486–492. 9 indexed citations
17.
Turpin, Elisabeth, et al.. (1979). Interaction between the Ricinus sanguineus agglutinin and receptor sites isolated from normal human lymphocytes. Biochimie. 61(1). 17–22. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026